Peng, Yong

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis

Oncotarget | April 22, 2016 | Volume: 7 | Issue: 24 | Pages: 36382-36394

10.18632/oncotarget.8871 | PMID 27144331